We provide 1 form of Ibrutinib
Ibrutinib
936563-96-1
|
440.497
|
4.069
Ibrutinib is an antineoplastic agent used to treat chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenstrom's Macroglobulinemia.
IBR | PCI-32765 | ibrutinib | imbruvica
Ibrutinib is an antineoplastic agent used to treat chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenstrom's Macroglobulinemia.
IBR | PCI-32765 | ibrutinib | imbruvica
$19/5 mg
(EBC)
1
We provide 0 compound for Ibrutinib